Biotech Briefing: Boston Scientific Acquires Vertiflex for $465 Million Plus Milestones

Vertiflex acquiredReports + Research Boston Scientific Acquires Vertiflex for $465 Million Plus Milestones Carlsbad-based Vertiflex makes a minimally invasive vertebrae spacer for treating lumbar stenosis, a narrowing of the spinal canal. Affecting an estimated six million people, the degenerative condition compresses nerves, leading to lower back and leg pain and numbness and trouble walking. According to FierceBiotech, …

The post Biotech Briefing: Boston Scientific Acquires Vertiflex for $465 Million Plus Milestones appeared first on Hatch.

Click to view original post

Advertise With Us